Validation of the Lithuanian Version of the Speech Handicap Index

Pribuišienė, Rūta; Liutkevičius, Vykintas; Pribuišis, Kipras; Uloza, Virgilijus

doi:10.1016/j.jvoice.2017.03.026

Cited by 10 publications

(7 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SHI is a universally adopted questionnaire used to assess the speech‐related QoL. Our studies and previous studies have established its reliability and validity 42–46 . Specifically, our results demonstrated that T 3 patients’ speech‐related QoL worsened significantly after surgery (see Table ).…”

Section: Discussionsupporting

confidence: 70%

Data mining of an acoustic biomarker in tongue cancers and its clinical validation

et al. 2021

View full text Add to dashboard Cite

The promise of speech disorders as biomarkers in clinical examination has been identified in a broad spectrum of neurodegenerative diseases. However, to the best of our knowledge, a validated acoustic marker with established discriminative and evaluative properties has not yet been developed for oral tongue cancers. Here we cross‐sectionally collected a screening dataset that included acoustic parameters extracted from 3 sustained vowels /ɑ/, /i/, /u/ and binary perceptual outcomes from 12 consonant‐vowel syllables. We used a support vector machine with linear kernel function within this dataset to identify the formant centralization ratio (FCR) as a dominant predictor of different perceptual outcomes across gender and syllable. The Acoustic analysis, Perceptual evaluation and Quality of Life assessment (APeQoL) was used to validate the FCR in 33 patients with primary resectable oral tongue cancers. Measurements were taken before (pre‐op) and four to six weeks after (post‐op) surgery. The speech handicap index (SHI), a speech‐specific questionnaire, was also administrated at these time points. Pre‐op correlation analysis within the APeQoL revealed overall consistency and a strong correlation between FCR and SHI scores. FCRs also increased significantly with increasing T classification pre‐operatively, especially for women. Longitudinally, the main effects of T classification, the extent of resection, and their interaction effects with time (pre‐op vs. post‐op) on FCRs were all significant. For pre‐operative FCR, after merging the two datasets, a cut‐off value of 0.970 produced an AUC of 0.861 (95% confidence interval: 0.785–0.938) for T3‐4 patients. In sum, this study determined that FCR is an acoustic marker with the potential to detect disease and related speech function in oral tongue cancers. These are preliminary findings that need to be replicated in longitudinal studies and/or larger cohorts.

show abstract

Section: Discussionsupporting

confidence: 70%

Data mining of an acoustic biomarker in tongue cancers and its clinical validation

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Any damage causes problems and limitations in social functioning and greatly affects the quality of life. In patients with oral and oropharyngeal cancer, due to the tumor location, the most important organs of the oral and articulation functions are affected [16,18,23]. Patients with H&N cancer are often disappointed with their communication efforts.…”

Section: Discussionmentioning

confidence: 99%

“…The purpose of this study was to investigate the psychometric properties as well as confirmatory factor anal-ysis of the SHI specific to the Persian language. The SHI has been validated in other languages with considerable success (e.g., Dutch, English, French, Korean, Chinese, Lithuanian, and Italian) [2, 12,16,18,[23][24][25][26]. In the cultural adaptation of the Persian version of the SHI, no item was removed.…”

Section: Discussionmentioning

confidence: 99%

“…Therefore, the use of an instrument designed to assess voice impairment in patients with H&N cancer may not be appropriate for the evaluation of speech problems. Further, voice-specific questionnaires ignore important information about the function of the nonlaryngeal vocal tract (e.g., articulation and speech intelligibility) and do not attend to the essential components of speech [10,16]. Therefore, given the importance of drawing a distinction between voice and speech in these patients, attention must be paid to the tools used for their specific and accurate examination [8,17].…”

Section: Introductionmentioning

confidence: 99%

“…The SHI has been adapted across multiple languages and cultures (e.g., English, French, Korean, Chinese, Lithuanian, and Italian) [2, 12,16,[23][24][25][26]. However, there have been no validated versions of the SHI in the Middle East.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Cross-Cultural Adaptation and Validation of the Speech Handicap Index into Persian

Bakhsh¹,

Moradi²,

Naderifar³

et al. 2021

Folia Phoniatr Logop

View full text Add to dashboard Cite

Purpose: The aim of the present study was to adapt and validate the Speech Handicap Index (SHI) into the Persian language. Patients and Methods: The original published English version of the SHI was translated into Persian using the translation protocol and guidelines of the International Quality of Life Assessment. One hundred participants with oral and oropharyngeal cancer and 40 healthy participants completed the Persian SHI. Forty participants of the patient group completed the Persian SHI a second time after a 2-weeks period to evaluate test-retest reliability. Content validity (content validity index and content validity ratio), internal consistency (Cronbach α coefficient), test-retest reliability (intraclass correlations), and construct validity (confirmatory factor analysis) were examined. Control group and patient group values were compared to determine the clinical validity. Results: A significant discrimination coefficient was found across all items, and the content and clinical validity were found to be acceptable. The Persian SHI showed a high internal consistency and test-retest reliability. The construct validity was within the acceptable range. Conclusions: The P-SHI is considered to be a valid and reliable questionnaire for speech assessment in Persian-speaking patients with head and neck cancer.

show abstract

Validation and Psychometric Evaluation of the Kannada Version of the Speech Handicap Index in Individuals with Oral and Oropharyngeal Cancer

Bhat

Balasubramanium

Krishnamurthy

et al. 2021

Indian J Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

Validation of the Lithuanian Version of the Speech Handicap Index

Cited by 10 publications

References 21 publications

Data mining of an acoustic biomarker in tongue cancers and its clinical validation

Data mining of an acoustic biomarker in tongue cancers and its clinical validation

Cross-Cultural Adaptation and Validation of the Speech Handicap Index into Persian

Validation and Psychometric Evaluation of the Kannada Version of the Speech Handicap Index in Individuals with Oral and Oropharyngeal Cancer

Contact Info

Product

Resources

About